{"id":17259,"date":"2026-08-19T12:44:35","date_gmt":"2026-08-19T12:44:35","guid":{"rendered":"https:\/\/turkblogs.com\/fda-accepts-ecopipam-tourette-treatment\/"},"modified":"2026-08-19T12:44:55","modified_gmt":"2026-08-19T12:44:55","slug":"fda-accepts-ecopipam-tourette-treatment","status":"publish","type":"post","link":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/","title":{"rendered":"FDA Accepts New Drug Application for Pediatric Tourette Treatment"},"content":{"rendered":"<p>Finding effective medical management options for pediatric patients has long been a significant challenge for caregivers and medical professionals alike. Recently, an encouraging therapeutic development emerged as <a href=\"https:\/\/vertexaisearch.cloud.google.com\/grounding-api-redirect\/AUZIYQH-XhYl1kMOcU4kVeZClycLDC7CYiX7kOElGWFSC8cdyCtj501RF7ntk51SqKQowO7VPh3hcIaC7Z5f9LDUmhKoHRzYaQ1TunDR6ijjYLla3z-_euXHspzqtZHgsUYCAO7FmpM-I4BHq2Rqx2vAComXiD6dx-wqN9IKADVRGGUO0ipTnfTQm8F4BhbLWhs0hRLMyMfIqiH0jMeiJANKw9pePeKfnfvSrva3HiC3Av3e6sCuuvlvUUVnipyr97I3cwojw1jN4qJ2JHnxcWFMETYi3EUqpJvkmh6OmmWFJ2ondfqVM8jvsBdCxizTeHUOmYeH_on34nUYVsnw6EWY7wbApZl750opDiu7pXierbn9s5wl8YUK0zi6ha4oFZ07R-BqQB6AJnbx81ghVqcn-0MzUsjhW1Mxf4iUTLaPw5GY58kUWvYA\" target=\"_blank\" rel=\"noopener noreferrer\">Teva Pharmaceutical Industries<\/a> announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for the investigational treatment <a href=\"https:\/\/turkblogs.com\/en\/reduce-sugar-intake-in-children\/\">Ecopipam<\/a>. This regulatory milestone brings renewed optimism to parents and individuals seeking advanced solutions for managing symptoms associated with pediatric Tourette syndrome, a condition historically characterized by severely limited pharmacological options.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp\" alt=\"Doctor discussing medical options with a family in a pediatric clinic\" style=\"width:100%;height:auto;\" loading=\"lazy\" \/><\/p>\n<ul>\n<li>Teva Pharmaceutical announced the FDA acceptance of the New Drug Application for Ecopipam.<\/li>\n<li>The medication has been granted priority review for treating pediatric Tourette syndrome.<\/li>\n<li>Clinical trial results demonstrate evaluated safety and efficacy data.<\/li>\n<li>The final FDA decision regarding approval is expected by the end of the first quarter of 2027.<\/li>\n<\/ul>\n<nav class=\"table-of-contents\" aria-label=\"Table of Contents\">\n<ul>\n<li><a href=\"#fda-grants-priority-review-to-ecopipam-for-pediatric-tourette-syndrome\">FDA Grants Priority Review to Ecopipam for Pediatric Tourette Syndrome<\/a><\/li>\n<li style=\"margin-inline-start:1.2em;\"><a href=\"#understanding-ecopipam-and-its-mechanism\">Understanding Ecopipam and Its Mechanism<\/a><\/li>\n<li><a href=\"#clinical-trial-results-and-safety-data\">Clinical Trial Results and Safety Data<\/a><\/li>\n<li><a href=\"#the-broader-impact-on-daily-life-and-comprehensive-care\">The Broader Impact on Daily Life and Comprehensive Care<\/a><\/li>\n<li><a href=\"#what-this-means-for-children-and-families\">What This Means for Children and Families<\/a><\/li>\n<li style=\"margin-inline-start:1.2em;\"><a href=\"#expected-timeline-for-fda-approval-by-2027\">Expected Timeline for FDA Approval by 2027<\/a><\/li>\n<\/ul>\n<\/nav>\n<h2 id=\"fda-grants-priority-review-to-ecopipam-for-pediatric-tourette-syndrome\">FDA Grants Priority Review to Ecopipam for Pediatric Tourette Syndrome<\/h2>\n<p>The decision by the regulatory agency to accept the filing under priority review underscores the urgent medical need for novel therapies targeting movement disorders in young patients. Ecopipam is specifically designed to address the unique neurological mechanisms underlying pediatric Tourette syndrome. By offering a targeted approach, this investigational treatment aims to fill a major therapeutic gap for children who do not respond adequately to current management strategies or who experience limiting side effects from older medications.<\/p>\n<h3 id=\"understanding-ecopipam-and-its-mechanism\">Understanding Ecopipam and Its Mechanism<\/h3>\n<p>What is Ecopipam used for? Ecopipam is an investigational medication specifically studied for the treatment of pediatric Tourette syndrome, a neurological disorder characterized by involuntary tics. Unlike traditional dopamine receptor antagonists that block D2 receptors, Ecopipam acts as a selective dopamine D1 receptor antagonist, potentially reducing tic severity while avoiding certain adverse effects associated with conventional therapies.<\/p>\n<div style=\"background:#eef2ff;border-inline-start:4px solid #4f46e5;padding:12px 16px;margin:16px 0;border-radius:6px;\"><strong>Clinical Note:<\/strong> Priority review status is reserved for drugs that, if approved, would provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions.<\/div>\n<h2 id=\"clinical-trial-results-and-safety-data\">Clinical Trial Results and Safety Data<\/h2>\n<p>The regulatory filing submitted by Teva Pharmaceutical Industries is supported by comprehensive data gathered from advanced clinical trials. These studies were meticulously structured to evaluate both the therapeutic efficacy and the safety profile of the medication in a pediatric demographic. While navigating chronic neurological conditions requires careful medical oversight, the positive findings from these trials provide a solid foundation for the ongoing evaluation by the regulatory authorities.<\/p>\n<h2 id=\"the-broader-impact-on-daily-life-and-comprehensive-care\">The Broader Impact on Daily Life and Comprehensive Care<\/h2>\n<p>Managing pediatric neurological conditions extends far beyond pharmaceutical interventions. Comprehensive care plans for children diagnosed with Tourette syndrome often incorporate behavioral therapies, psychological counseling, supportive school environments, and holistic lifestyle adjustments. For instance, maintaining balanced nutrition, establishing predictable daily routines, and managing dietary factors such as overall sugar consumption can play a supportive role in a child&#8217;s general well-being and stress management. Although diet alone does not cure neurological tics, a holistic approach helps families create a stable, low-stress environment that complements medical treatments like Ecopipam.<\/p>\n<h2 id=\"what-this-means-for-children-and-families\">What This Means for Children and Families<\/h2>\n<p>For families managing the daily realities of Tourette syndrome, the prospect of a new targeted medication represents a vital shift in disease management. Limited therapeutic choices have historically left many caregivers searching for better ways to improve their children&#8217;s quality of life. The advancement of Ecopipam through the regulatory pipeline highlights ongoing scientific progress in addressing complex pediatric neurological disorders.<\/p>\n<h3 id=\"expected-timeline-for-fda-approval-by-2027\">Expected Timeline for FDA Approval by 2027<\/h3>\n<p>Medical professionals, researchers, and families are closely monitoring the regulatory schedule. When will the FDA make a decision on Ecopipam? The U.S. Food and Drug Administration is expected to issue its final decision regarding the approval of the New Drug Application by the end of the first quarter of 2027. Until that time, clinical investigations and continued safety monitoring remain critical components of the development process.<\/p>\n<p>As the healthcare community awaits the final regulatory review, the acceptance of the NDA marks a crucial step forward. Families affected by pediatric Tourette syndrome can look toward upcoming clinical milestones with grounded optimism as researchers continue working toward expanding available therapeutic options.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"headline\": \"FDA Accepts New Drug Application for Pediatric Tourette Treatment\", \"description\": \"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.\", \"inLanguage\": \"en\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/\"}, \"datePublished\": \"2026-08-19T12:44:54\", \"dateModified\": \"2026-08-19T12:44:54\", \"publisher\": {\"@type\": \"Organization\", \"name\": \"Turk Blogs\", \"url\": \"https:\/\/turkblogs.com\", \"logo\": {\"@type\": \"ImageObject\", \"url\": \"https:\/\/turkblogs.com\/wp-content\/uploads\/2023\/11\/tr-blogo-logo-png.png\"}, \"sameAs\": [\"https:\/\/www.facebook.com\/profile.php?id=61554105234628\", \"https:\/\/www.instagram.com\/turkblogs\/\", \"https:\/\/twitter.com\/turkblogs\", \"https:\/\/www.youtube.com\/channel\/UCUvClZgrOsk5EftH9UalIIw\"]}, \"image\": [\"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp\"]}<\/script><br \/>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"What is Ecopipam used for?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Ecopipam is an investigational drug studied for the treatment of pediatric Tourette syndrome, aiming to reduce involuntary tics by selectively blocking dopamine D1 receptors.\"}}, {\"@type\": \"Question\", \"name\": \"When will the FDA make a decision on Ecopipam?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The U.S. Food and Drug Administration is expected to issue its final decision regarding the approval of Ecopipam by the end of the first quarter of 2027.\"}}, {\"@type\": \"Question\", \"name\": \"What are the treatment options for Tourette syndrome in children?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Current options include behavioral therapies and conventional medications like dopamine antagonists, though many patients experience limited efficacy or side effects, creating a strong need for new treatments like Ecopipam.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration has granted priority review to the investigational medication Ecopipam for children with Tourette syndrome.<\/p>\n","protected":false},"author":1,"featured_media":17254,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[51],"tags":[],"class_list":{"0":"post-17259","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health"},"wpml_debug":"{\"has_action_before\":\"yes\",\"lang\":null,\"translation_of\":null,\"skipped\":\"no_lang_param\"}","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA Accepts New Drug Application for Pediatric Tourette Treatment<\/title>\n<meta name=\"description\" content=\"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Accepts New Drug Application for Pediatric Tourette Treatment\" \/>\n<meta property=\"og:description\" content=\"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Turk Blogs\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61554105234628\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-19T12:44:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-19T12:44:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1408\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Bedir KAYA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@turkblogs\" \/>\n<meta name=\"twitter:site\" content=\"@turkblogs\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bedir KAYA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/\"},\"author\":{\"name\":\"Bedir KAYA\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#\\\/schema\\\/person\\\/c80e947f9053fd02278fab3e1aa4adb9\"},\"headline\":\"FDA Accepts New Drug Application for Pediatric Tourette Treatment\",\"datePublished\":\"2026-08-19T12:44:35+00:00\",\"dateModified\":\"2026-08-19T12:44:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/\"},\"wordCount\":718,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ecopipam-tourette-clinical-trial-children.webp\",\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/\",\"url\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/\",\"name\":\"FDA Accepts New Drug Application for Pediatric Tourette Treatment\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ecopipam-tourette-clinical-trial-children.webp\",\"datePublished\":\"2026-08-19T12:44:35+00:00\",\"dateModified\":\"2026-08-19T12:44:55+00:00\",\"description\":\"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ecopipam-tourette-clinical-trial-children.webp\",\"contentUrl\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/ecopipam-tourette-clinical-trial-children.webp\",\"width\":1408,\"height\":768,\"caption\":\"\u0637\u0628\u064a\u0628 \u0645\u062e\u062a\u0635 \u064a\u0646\u0627\u0642\u0634 \u0646\u062a\u0627\u0626\u062c \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0644\u062f\u0648\u0627\u0621 \u0645\u062a\u0644\u0627\u0632\u0645\u0629 \u062a\u0648\u0631\u064a\u062a \u0644\u0644\u0623\u0637\u0641\u0627\u0644\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/fda-accepts-ecopipam-tourette-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Accepts New Drug Application for Pediatric Tourette Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/\",\"name\":\"Turk Blogs\",\"description\":\"Discover the latest news and articles about Turkey and the world on Turk Blogs. Follow us for reliable information and in-depth analyses covering everything that matters to you.\",\"publisher\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#organization\",\"name\":\"Turk Blogs\",\"url\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/tr-blogo-logo-icon.png\",\"contentUrl\":\"https:\\\/\\\/turkblogs.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/tr-blogo-logo-icon.png\",\"width\":100,\"height\":100,\"caption\":\"Turk Blogs\"},\"image\":{\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61554105234628\",\"https:\\\/\\\/x.com\\\/turkblogs\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/#\\\/schema\\\/person\\\/c80e947f9053fd02278fab3e1aa4adb9\",\"name\":\"Bedir KAYA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g\",\"caption\":\"Bedir KAYA\"},\"sameAs\":[\"https:\\\/\\\/turkblogs.com\"],\"url\":\"https:\\\/\\\/turkblogs.com\\\/en\\\/author\\\/invest55332\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Accepts New Drug Application for Pediatric Tourette Treatment","description":"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/","og_locale":"en_US","og_type":"article","og_title":"FDA Accepts New Drug Application for Pediatric Tourette Treatment","og_description":"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.","og_url":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/","og_site_name":"Turk Blogs","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61554105234628","article_published_time":"2026-08-19T12:44:35+00:00","article_modified_time":"2026-08-19T12:44:55+00:00","og_image":[{"width":1408,"height":768,"url":"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp","type":"image\/webp"}],"author":"Bedir KAYA","twitter_card":"summary_large_image","twitter_creator":"@turkblogs","twitter_site":"@turkblogs","twitter_misc":{"Written by":"Bedir KAYA","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#article","isPartOf":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/"},"author":{"name":"Bedir KAYA","@id":"https:\/\/turkblogs.com\/en\/#\/schema\/person\/c80e947f9053fd02278fab3e1aa4adb9"},"headline":"FDA Accepts New Drug Application for Pediatric Tourette Treatment","datePublished":"2026-08-19T12:44:35+00:00","dateModified":"2026-08-19T12:44:55+00:00","mainEntityOfPage":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/"},"wordCount":718,"commentCount":0,"publisher":{"@id":"https:\/\/turkblogs.com\/en\/#organization"},"image":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp","articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/","url":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/","name":"FDA Accepts New Drug Application for Pediatric Tourette Treatment","isPartOf":{"@id":"https:\/\/turkblogs.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#primaryimage"},"image":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp","datePublished":"2026-08-19T12:44:35+00:00","dateModified":"2026-08-19T12:44:55+00:00","description":"The FDA has accepted the New Drug Application for Ecopipam to treat pediatric Tourette syndrome, offering new hope for families and patients.","breadcrumb":{"@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#primaryimage","url":"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp","contentUrl":"https:\/\/turkblogs.com\/wp-content\/uploads\/2026\/08\/ecopipam-tourette-clinical-trial-children.webp","width":1408,"height":768,"caption":"\u0637\u0628\u064a\u0628 \u0645\u062e\u062a\u0635 \u064a\u0646\u0627\u0642\u0634 \u0646\u062a\u0627\u0626\u062c \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0644\u062f\u0648\u0627\u0621 \u0645\u062a\u0644\u0627\u0632\u0645\u0629 \u062a\u0648\u0631\u064a\u062a \u0644\u0644\u0623\u0637\u0641\u0627\u0644"},{"@type":"BreadcrumbList","@id":"https:\/\/turkblogs.com\/en\/fda-accepts-ecopipam-tourette-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/turkblogs.com\/en\/"},{"@type":"ListItem","position":2,"name":"FDA Accepts New Drug Application for Pediatric Tourette Treatment"}]},{"@type":"WebSite","@id":"https:\/\/turkblogs.com\/en\/#website","url":"https:\/\/turkblogs.com\/en\/","name":"Turk Blogs","description":"Discover the latest news and articles about Turkey and the world on Turk Blogs. Follow us for reliable information and in-depth analyses covering everything that matters to you.","publisher":{"@id":"https:\/\/turkblogs.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/turkblogs.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/turkblogs.com\/en\/#organization","name":"Turk Blogs","url":"https:\/\/turkblogs.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/turkblogs.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/turkblogs.com\/wp-content\/uploads\/2023\/11\/tr-blogo-logo-icon.png","contentUrl":"https:\/\/turkblogs.com\/wp-content\/uploads\/2023\/11\/tr-blogo-logo-icon.png","width":100,"height":100,"caption":"Turk Blogs"},"image":{"@id":"https:\/\/turkblogs.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61554105234628","https:\/\/x.com\/turkblogs"]},{"@type":"Person","@id":"https:\/\/turkblogs.com\/en\/#\/schema\/person\/c80e947f9053fd02278fab3e1aa4adb9","name":"Bedir KAYA","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6fc6aa9fc4b8c21f6622cf94889a482227ef0c6018e0d0fa080dba904dd8b55d?s=96&d=mm&r=g","caption":"Bedir KAYA"},"sameAs":["https:\/\/turkblogs.com"],"url":"https:\/\/turkblogs.com\/en\/author\/invest55332\/"}]}},"_links":{"self":[{"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/posts\/17259","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/comments?post=17259"}],"version-history":[{"count":1,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/posts\/17259\/revisions"}],"predecessor-version":[{"id":17260,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/posts\/17259\/revisions\/17260"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/media\/17254"}],"wp:attachment":[{"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/media?parent=17259"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/categories?post=17259"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/turkblogs.com\/en\/wp-json\/wp\/v2\/tags?post=17259"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}